Charcot-Marie-Tooth
9
6
7
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (9)
Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP
Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
The Myelin Disorders Biorepository Project
Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study
NuroSleeve Powered Brace & Stimulation System to Restore Arm Function
Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
Natural History Study for Charcot Marie Tooth Disease
Physical Activity in Persons With Charcot-Marie-Tooth: Developing a Measurement Instrument